Moreover, activation of A1ARs expressed by peripheral blood mononuclear cells (PBMCs) significantly reduces TNF-α but not IL-6 levels in control subjects, with the opposite occurring in RR-MS patients, in which reduced levels of A1ARs were also observed [57]. This evidence concerns the gene IL6 and myeloid sarcoma.